October, 2019
Cannabinoids for Psychiatric Disorders? Evidence of Effectiveness is Lacking, Report Concludes
American Psychiatric Association Tues, Oct 29, 2019 There is little evidence that the use of cannabinoids can improve symptoms of anxiety, attention-deficit/hyperactivity disorder (ADHD), depression, posttraumatic stress disorder (PTSD), psychosis, or Tourette syndrome, according to a report in Lancet Psychiatry. “Cannabinoids are often advocated as a treatment for various mental disorders,” wrote Nicola Black,... read more
Americans increasingly fear violence from people who are mentally ill. They shouldn't
Los Angeles Times By Melissa Healy Oct 10, 2019 Political rhetoric that blames people with mental illness for spasms of mass violence appears to be seeping into the national psyche. Americans increasingly see people with schizophrenia or major depression as a threat not only to themselves but to others, new research reveals.... read more
Interventions to Prevent Psychosis
The New York Times By Jane E. Brody Sept 2, 2019 An impending psychotic break can be identified and prevented if it is recognized early and appropriate steps are taken to head it off. Tiffany Martinez was a 17-year-old college freshman when she began hearing voices, seeing shadowy figures and... read more
When Depression Is Like a Cancer
The New York Times By Jill Halper, M.D. Sept 26, 2019 Like cancer, depression is a chronic disease that may be cured. But for some patients, both diseases may ultimately prove fatal, even with state-of-the-art care and resources. Depression is not cancer. It’s a completely different disease. Yet when I look back on... read more